Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for cancer drug selumetinib and is demanding at least $192 million from the pharma giant, according to the complaint filed with the New York Supreme Court.
Ook interessant voor je
Reageer